Andere talen TELA Bio, Inc.

Aandelen

TELA

US8723811084

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,45 ^USD	+1,37%		-6,32%	-32,78%

15/04	TELA Bio, Inc. Kondigt de commerciële lancering in de VS aan van OviTex IHR dat compatibel is met robots	CI
22/03	TELA BIO, INC. : Piper Sandler herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

TELA Bio to Announce First Quarter 2024 Financial Results	25/04
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	16/04
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	15/04
TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR	15/04
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	08/04
Earnings Flash (TELA) TELA BIO Reports Q4 Revenue $17M, vs. Street Est of $16.4M	21/03
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/03
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	21/03
TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024	21/03
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	21/03
TELA Bio, Inc. Announces U.S. Commercial Launch of LIQUIFIX	21/03
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20/03
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	20/03
MiMedx Group, Inc. Enters into an Agreement with Tela Bio, Inc. to Obtain Exclusive Rights to Its Manufacturing and Supply Agreement	20/03
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/02
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TELA Bio, Inc.

Aandelen

TELA

US8723811084

Andere talen

Filters